3Chopt Investment Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$683K Buy
+11,859
New +$681K 0.13% 130
2026
Q1
Sell
-12,138
Closed -$655K 246
2025
Q4
$655K Sell
12,138
-14,322
-54% -$689K 0.15% 120
2025
Q3
$1.19M Sell
26,460
-36,326
-58% -$1.7M 0.27% 85
2025
Q2
$2.91M Buy
62,786
+5,760
+10% +$283K 0.7% 34
2025
Q1
$3.48M Buy
57,026
+4,021
+8% +$234K 0.91% 25
2024
Q4
$3M Buy
53,005
+2,726
+5% +$152K 1.03% 31
2024
Q3
$2.6M Buy
50,279
+4,940
+11% +$232K 0.93% 38
2024
Q2
$1.88M Buy
45,339
+7,465
+20% +$334K 0.57% 42
2024
Q1
$2.05M Buy
37,874
+10,923
+41% +$556K 0.84% 39
2023
Q4
$1.38M Buy
26,951
+4,640
+21% +$244K 0.51% 55
2023
Q3
$1.29M Buy
22,311
+6,894
+45% +$422K 0.76% 42
2023
Q2
$986K Buy
15,417
+3,584
+30% +$240K 0.49% 58
2023
Q1
$820K Buy
11,833
+6,545
+124% +$462K 0.44% 66
2022
Q4
$380K Buy
+5,288
New +$399K 0.21% 94

Other funds holding BMY

3Chopt Investment Partners's BMY Position: Q2 2026 in Review

3Chopt Investment Partners opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 11,859 shares worth $683K. The stake represents 0.13% of the portfolio and ranks #130 among its holdings. This is a return to the name: 3Chopt Investment Partners previously reported a position in BMY as recently as Q4 2025.

3Chopt Investment Partners first reported a position in BMY in Q4 2022 and has held it in 14 quarters since. The position peaked at $3.48M in Q1 2025. 1,158 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • 3Chopt Investment Partners held 11,859 shares of Bristol-Myers Squibb worth $683K as of Q2 2026.
  • Bristol-Myers Squibb was a new 3Chopt Investment Partners position in Q2 2026.
  • Bristol-Myers Squibb made up 0.13% of 3Chopt Investment Partners's portfolio in Q2 2026, its #130 holding.
  • 3Chopt Investment Partners first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 14 quarters since.
  • 3Chopt Investment Partners's Bristol-Myers Squibb position peaked at $3.48M in Q1 2025.
  • 1,158 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on 3Chopt Investment Partners's 13F filing for Q2 2026, filed 29 Jul 2026.